---
document_datetime: 2023-09-21 19:12:08
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/sycrest-epar-all-authorised-presentations_en.pdf
document_name: sycrest-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.9840537
conversion_datetime: 2025-12-25 06:31:59.572806
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical form   | Route of administration   | Immediate Packaging   | Pack size   |
|------------------|-------------------|------------|-----------------------|---------------------------|-----------------------|-------------|
| EU/1/10/640/001  | Sycrest           | 5 mg       | Sublingual tablet     | Sublingual use            | blister (alu/alu)     | 20 tablets  |
| EU/1/10/640/002  | Sycrest           | 5 mg       | Sublingual tablet     | Sublingual use            | blister (alu/alu)     | 60 tablets  |
| EU/1/10/640/003  | Sycrest           | 5 mg       | Sublingual tablet     | Sublingual use            | blister (alu/alu)     | 100 tablets |
| EU/1/10/640/004  | Sycrest           | 10 mg      | Sublingual tablet     | Sublingual use            | blister (alu/alu)     | 20 tablets  |
| EU/1/10/640/005  | Sycrest           | 10 mg      | Sublingual tablet     | Sublingual use            | blister (alu/alu)     | 60 tablets  |
| EU/1/10/640/006  | Sycrest           | 10 mg      | Sublingual tablet     | Sublingual use            | blister (alu/alu)     | 100 tablets |